"Resverlogix has partnered with EVERSANA ™, a pioneer of next generation commercial services to the global life sciences industry, to support the rapid commercialization of apabetalone for COVID-19 in Canada and the United States."
top of page
Recent PostsSee All
Revive will remain with the current protocol’s primary endpoint of proportion of patients meeting an endpoint of hospitalization or death..
Rakovina Therapeutics’ management will deliver a brief corporate overview and then be available for questions and discussions...
bottom of page